Item 7.01 Regulation FD Disclosure.
Medicus Sciences Acquisition Corp. (the "Company") has approached Anteris
Technologies Ltd ("Anteris"), a company listed on the Australian Securities
Exchange ("ASX"), with a proposal to enter into discussions regarding a possible
business combination transaction and to negotiate a non-binding letter of intent
in contemplation of such a possible transaction. As of the date of this filing,
there is no letter of intent in effect between the Company and Anteris and
related discussions are ongoing. Nevertheless, Anteris made a determination that
pursuant to applicable Australian securities laws, it was required to make a
public announcement disclosing that it had been approached by the Company, which
it did on February 8, 2022.
Sio Capital Management, LLC is both (i) the holder of a significant equity
interest in the Company's sponsor, Medicus Sciences Holdings LLC, and (ii) a
significant direct and indirect holder of shares in Anteris. Pursuant to
Australian securities laws, the Company has filed, or will simultaneously
herewith file, a notice with the ASX in connection with these relationships. The
Company is not a direct or beneficial owner of any shares or other securities of
Anteris.
The information set forth below under this Item 7.01 is intended to be furnished
and shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended ("Exchange Act") or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended or the Exchange Act,
except as expressly set forth by specific reference in such filing.
© Edgar Online, source Glimpses
MEDICUS SCIENCES ACQUISITION CORP. 